Although we do not know the exact molecular mechanism whereby CHI3L1 governs prolonged inflammation after MI, it appears that inhibition of CHI3L1 may be beneficial to limit cardiac dysfunction in acute and chronic heart failure due to MI. This evidence concerns the gene CHI3L1 and myocardial infarction.